
研究成果
年分
              作者
              期刊
              研究名稱
            2022
                Chao TF*, Chan YH, Chiang CE, Tuan TC, Liao JN, Chen TJ, Lip GYH, Chen SA.
                Thromb. Haemost. 2022; 122(11):1899-1910. (IF:6.830)         
                Early Rhythm Control and the Risks of Ischemic Stroke,...Diagnosed Patients with Atrial Fibrillation.
              2022
                Chao TF*, Chan YH, Chiang CE, Tuan TCA, Liao JN, Chen TJ, Lip GYH, Chen SA.
                Clin. Res. Cardiol. 2022; 111(1):23-33. (IF: 6.138)         
                Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation.
              2022
                Chao TF*, Chan YH, Tuan TC, Liao JN, Chen TJ, Lip GYH, Chen SA.
                Eur. Heart J.-Qual. Care Clin. Outcomes. 2022; 8(5): 588-595. (IF: 7.064)         
                Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study.
              2022
                Chao TF*, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, Guo YT, Sriratanasathavorn C, Oh S, Okumura K, Lip GYH.
                Thromb. Haemost. 2022; 122(01) 20-47. (IF:6.830)         
                2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
              2022
                Chao TF*, Tse HF, Teo WS, Park HW, Shimizu W, Chen SA, Lip GYH.
                Eur. J. Clin. Invest. 2022; 52(10): e13825. (IF:5.722)         
                Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.
              2022
                Chen CT, Lin JW, Wu CH, Kuo RNC, Shih CH, Hou PC*, Yen DHT, How CK.
                Crit. Care Med. 2022; 50(3): 428-439. (IF: 9.296)         
                A Simple Risk Score for Predicting Neurologic Outcome in Out-of-Hospital Cardiac Arrest Patients After Targeted Temperature Management*.
              2022
                Chen HY, Huang WC, Teng HI, Tsai CT, Tsai YL, Chuang MJ, Chen YY, Lu TM*.
                J. Chin. Med. Assoc. 2022; 85(5): 543-548. (IF: 3.396)         
                Effects of aggressive predilatation, sizing, and postdilatation strategy for coronary bioresorbable vascular scaffolds implantation.
              2022
                Chen PS, Lee M, Tang SC, Huang PH, Yeh H, Hou CJY, Hsieh C, Lee JT, Jeng JS*, Li YH*.
                J. Formos. Med. Assoc. 2022; 121(8): 1363-1370. (IF: 3.871)         
                2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: Coronary artery disease, peripheral artery disease and ischemic stroke.
              2022
                Chen WT, Ahliah I, Chung FP*.
                Heart Lung Circ. 2022; 31(9): E126-E128. (IF: 2.838)         
                Pseudo-Conduction in the Mitral Isthmus After Ablation.
              2022
                Chen WT, Chi NF, Cheng HM, Ko YT, Chuang SY, Pan WH, Chen CH, Chung CP, Wang PN*.
                J. Alzheimers Dis. 2022; 86(2): 679-690. (IF: 4.160)         
                Associations Between Cerebral Vasoreactivity and Cognitive Function in the Middle-Aged Non-Demented Population.
              


